LIDOCAINE 5%- lidocaine cream 
Apnar Pharma LP

----------

Lidocaine 5% Anorectal Cream

Lidocaine 5% w/w

Local Anesthetic

Uses Temporarily relieves pain and itching due to anorectal disorders

When using this product

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

Store at room temperature 20-25°C (68-77°F); Excursions permitted 15-30°C (59-86°F) [see USP Controlled Room Temperature].

Benzyl Alcohol, Carbopol 940 (Carbomer 940), Hydrogenated Lecithin, Isopropyl Myristate, Polysorbate 80, Propylene Glycol, Purified Water, Trolamine, and Vitamin E Acetate (Alpha Tocophferol Acetate)

DOSAGE

50 miligrams/gram per application

USAGE

Adults and children 12 years and older: Apply externally to the affected area up to 6 times a day.
Children under 12 years of age: Consult a doctor

NDC 24689-124-01

Lidocaine 5% Anorectal Cream

Apnar Pharma LP

Net.Wt 30 grams

Lidocaine cream caron

LIDOCAINE 5% 
lidocaine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24689-124
Route of AdministrationRECTAL, TOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CARBOMER 940 (UNII: 4Q93RCW27E)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
WATER (UNII: 059QF0KO0R)  
TROLAMINE (UNII: 9O3K93S3TK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24689-124-011 in 1 CARTON11/01/2021
130 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01511/01/2021
Labeler - Apnar Pharma LP (079568229)
Establishment
NameAddressID/FEIBusiness Operations
Invaderm078610697analysis(24689-124) , manufacture(24689-124) , pack(24689-124)

Revised: 10/2023
Document Id: 0836052f-6382-9f0f-e063-6294a90a1e98
Set id: ceedce20-5723-5a9a-e053-2a95a90a17a1
Version: 2
Effective Time: 20231021
 
Apnar Pharma LP